Adrian Newton Loucious MHP

Recommended Articles

• Marvel Comics Supports Cody Sheehan's Captain America Campaign for Cystic Fibrosis

  Cystic fibrosis is a genetic condition that afflicts individuals from birth. Over the years, the prognosis of the condition has gotten far better, but at one point in time, the disease was so devastating that individuals diagnosed at birth rarely lived past childhood. Such was the case for Cody...

• What to Expect After Chemotherapy

  Chemotherapy is a treatment for many types of cancer. Chemotherapy works in various ways in fighting cancer in the human body: It suppresses cancer cells from growth and spreading to other parts of the body, kills cancer cells hence stopping the condition, and can also reduce recurrence of cancer...

• Can My Child Develop COPD?

  Can COPD Develop in Children?By definition, COPD is a serious lung condition that has developed over a long period of time. Numerous studies explained that children cannot have COPD; however, the disease process can begin at a young age.One can observe the symptoms associated with COPD in a child,...

• Is Hair Dye Safe?

  Dying one's hair is a common routine for men and women who experience changes in the color of their hair as they age. Although long-term safety of these products are not clear, there are some precautionary measures to be followed while using a dye.One should consider the following before dying his...

• X-Factor Star Opens Up About Six-Year Battle with Crohn's

  23-year old pop star from South Wales, Lloyd Macey, spoke out about his six-year battle with Crohn’s disease, a long-term condition that triggers inflammation of the digestive system.At the age of 18, Lloyd was in the middle of his second year of studies at Cardiff University when one evening,...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...